Drug advertising shifts AI treatment recommendations
Text
A controlled study measures preferences, not patient harm.
Drug ads changed treatment preferences in tests of 12 AI models, Mount Sinai reports.
The institution reports the advertised drug was selected 47.6% of the time with an ad, versus 35% without one.
Cases and treatment options stayed unchanged. Promotional context influenced selection.
Several options could still be medically appropriate. The study did not measure prescriptions or patient outcomes.
Source dates: preprint April 16, 2026; Mount Sinai November 11.
Share this article
What do you think of this story?
Anonymous feedback, up to 5 reactions per article.
Anonymous comments
Share your thoughts without signing in.
Discuss the technology and the story. Hate, politics and war, threats, abuse, personal accusations, sexual content, ads, links and personal information are not allowed.
No comments yet. Be the first to share.